Mono Pharmacare Ltd
MONOPHARMA NSE
Mono Pharmacare Ltd
HealthcareNSE: MONOPHARMA Pharmaceuticals
Key Fundamentals
SMEPharmaceuticalsHealthcareMarket Cap
₹14.05 Cr
Volatility
Low Risk
P/E Ratio
4.01
EBITDA
₹3.99 Cr
Return on Equity
9.94%
Debt to Equity
1.75
Book Value
₹17.86
EPS
₹1.38
52W High
₹27.5
52W Low
₹8.25
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Mono Pharmacare Ltd insights
29 extracted metrics + investor summaries across FY23–FY25.
Tapetide Score
Data-driven rating, 0–100. How it works →
Technical Indicators
Key Insights
Strengths
1- Stock is trading at 0.44 times its book value
Weaknesses
5- Though the company is reporting repeated profits, it is not paying out dividend
- Company has low interest coverage ratio.
- Company has a low return on equity of 7.18% over last 3 years.
- Company might be capitalizing the interest cost
- Company has high debtors of 165 days.
Growth Rate
Revenue Growth
-2.13% ↘
Net Income Growth
-89.68% ↘
Cash Flow Change
50.97% ↗
ROE
13.73% ↗
ROCE
6.39% ↗
EBITDA Margin (Avg.)
-52.65% ↘
Quarterly Results
| Mar 2023 | Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Sales | 35 | 67 | 56 | 87 | 81 | 66 | 99 |
| Expenses | 33 | 63 | 53 | 82 | 78 | 65 | 97 |
| Operating Profit | 2 | 4 | 2 | 5 | 3 | 2 | 2 |
| OPM % | 6% | 6% | 4.4% | 5% | 3.6% | 2.7% | 2.2% |
| Other Income | 0 | 0 | 0 | 0 | 1 | 0 | 0 |
| Interest | 1 | 2 | 2 | 2 | 2 | 2 | 2 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| PBT | 1 | 2 | 1 | 3 | 1 | 0 | 0 |
| Tax % | 39% | 20% | 33% | 27% | 37% | 83% | 29% |
| Net Profit | 1 | 2 | 1 | 2 | 1 | 0 | 0 |
| EPS in Rs | 0.52 | 1.06 | 0.33 | 1.3 | 0.46 | 0.01 | 0.19 |
Profit & Loss
| Mar 2023 6m | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|
| Sales | 33 | 122 | 168 | 166 |
| Expenses | 31 | 116 | 161 | 162 |
| Operating Profit | 2 | 6 | 8 | 4 |
| OPM % | 7% | 5% | 4.5% | 2.4% |
| Other Income | 0 | 0 | 1 | 0 |
| Interest | 1 | 3 | 4 | 3 |
| Depreciation | 0 | 0 | 0 | 0 |
| PBT | 1 | 3 | 4 | 1 |
| Tax % | 29% | 24% | 30% | 40% |
| Net Profit | 1 | 2 | 3 | 0 |
| EPS in Rs | 0.76 | 1.38 | 1.75 | 0.2 |
| Div. Payout % | 0% | 0% | 0% | 0% |
Balance Sheet
| Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|
| Equity Capital | 12 | 18 | 18 | 18 |
| Reserves | 1 | 10 | 14 | 14 |
| Borrowings | 40 | 41 | 54 | 56 |
| Other Liabilities | 9 | 12 | 25 | 34 |
| Total Liabilities | 63 | 81 | 110 | 122 |
| Fixed Assets | 1 | 1 | 1 | 1 |
| CWIP | 0 | 0 | 0 | 0 |
| Investments | 1 | 0 | 0 | 0 |
| Other Assets | 61 | 80 | 109 | 121 |
| Total Assets | 63 | 81 | 110 | 122 |
Cash Flow
| Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|
| Operating | -40 | -9 | -4 | — |
| Investing | -1 | 0 | 0 | — |
| Financing | 41 | 8 | 5 | — |
| Net Cash Flow | 0 | 0 | 0 | — |
| Free Cash Flow | -40 | -9 | -5 | — |
| CFO/OP | -1,765 | -126 | -38 | — |
Ratios
| Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|
| Debtor Days | 241 | 94 | 91 | 165 |
| Inventory Days | 408 | 139 | 133 | 99 |
| Days Payable | 87 | 32 | 45 | 68 |
| Cash Conversion Cycle | 563 | 202 | 179 | 196 |
| Working Capital Days | 299 | 131 | 120 | 126 |
| ROCE % | — | 10% | 11% | 5% |
Documents
1
Resignation
16 Jul - Mono Pharmacare Limited has informed regarding Resignation of Mr Rahul Joshi as Company Secretary & Compliance Officer of the company w.e.f. July 01, 2026. 16 Jul - Mono Pharmacare Limited has informed regarding Resignation of Mr Rahul Joshi as Company Secretary & Compliance Officer of the company w.e.f. July 01, 2026.
2
Outcome of Board Meeting
16 Jul - Board approved FY26 audited standalone and consolidated results; noted company secretary resignation and auditor appointments on 16 July 2026. 16 Jul - Board approved FY26 audited standalone and consolidated results; noted company secretary resignation and auditor appointments on 16 July 2026.
3
Resignation of Director/KMP/SMP
16 Jul - Mono Pharmacare Limited has informed about Resignation of Director/KMP/SMP 16 Jul - Mono Pharmacare Limited has informed about Resignation of Director/KMP/SMP
4
Change in Auditors
16 Jul - BG Kalal & Co. consented to act as Internal Auditor for FY 2026-27. 16 Jul - BG Kalal & Co. consented to act as Internal Auditor for FY 2026-27.
5
General Updates
16 Jul - Surana and Kothari Associates LLP consents to act as Secretarial Auditor and Scrutinizer for FY 2026-27. 16 Jul - Surana and Kothari Associates LLP consents to act as Secretarial Auditor and Scrutinizer for FY 2026-27.
Frequently Asked Questions about Mono Pharmacare Ltd
What does Mono Pharmacare Ltd do?
Incorporated in 1994, Mono Pharmacare Ltd is in the business of distribution of Pharmaceutical items[1]
Where is Mono Pharmacare Ltd (MONOPHARMA) listed?
Mono Pharmacare Ltd is listed on the Indian stock exchanges. It is listed on NSE: MONOPHARMA. You can view its live share price, financials, and ratios on Tapetide.
Which sector does Mono Pharmacare Ltd belong to?
Mono Pharmacare Ltd operates in the Healthcare sector within the Pharmaceuticals industry. Sector classification helps investors compare companies affected by similar economic conditions and regulatory changes.
What is the market capitalisation of Mono Pharmacare Ltd?
Mono Pharmacare Ltd has a market capitalisation of approximately ₹14.05 Cr. Based on this, it is classified as a Small Cap stock.
What is the PE ratio of Mono Pharmacare Ltd?
The Price-to-Earnings (PE) ratio of Mono Pharmacare Ltd is 4.01. The PE ratio compares a company's share price to its earnings per share and is commonly used to assess whether a stock is overvalued or undervalued relative to its peers.
What is the 52-week high and low of Mono Pharmacare Ltd?
Over the past 52 weeks, Mono Pharmacare Ltd has traded between a low of ₹8.25 and a high of ₹27.5. This range helps investors understand the stock's price volatility and recent trading levels.
What is the Return on Equity (ROE) of Mono Pharmacare Ltd?
Mono Pharmacare Ltd has a Return on Equity (ROE) of 9.94%. ROE measures how effectively a company uses shareholders' equity to generate profits. A higher ROE generally indicates better capital efficiency.
How can I research Mono Pharmacare Ltd on Tapetide?
On Tapetide, you can view Mono Pharmacare Ltd's live share price, quarterly results, profit & loss statements, balance sheet, cash flow, key ratios, shareholding pattern, technical indicators, analyst ratings, and forecasts — all on a single page without needing to sign up.
Company Information
Incorporated in 1994, Mono Pharmacare Ltd is in the business of distribution of Pharmaceutical items[1]